Literature DB >> 27900050

Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.

Yoshikuni Inokawa1, Kenichi Inaoka1, Fuminori Sonohara1, Masamichi Hayashi2, Mitsuro Kanda2, Shuji Nomoto1.   

Abstract

Although hepatocellular carcinoma (HCC) is associated with poor prognosis worldwide, the molecular mechanisms underlying the carcinogenesis and progression of this disease remain unclear. Several tumor characteristics have previously been demonstrated to be prognostic factors of survival following hepatic resection, or the recurrence of HCC or other types of cancer. Comparisons of normal tissues and HCC tumor tissues have revealed the presence of numerous molecular alterations in HCC, including genetic and epigenetic mechanisms, particularly mutations in certain genes and DNA methylation in the promoter regions of tumor-suppressor genes. A number of studies have previously used array analysis to detect variations in the expression levels of cancer-associated genes and microRNAs, and in DNA methylation. However, an investigation of HCC tumor tissues may not determine the effect of noncancerous liver tissues (background liver) in patients with HCC. As HCC may recur multicentrically following resection, a damaged or chronically diseased HCC background liver may be considered as a pre-cancerous organ. Therefore, the influence of the background liver on HCC requires further study. Detailed studies regarding the background liver may be essential for the improved understanding of the carcinogenesis and progression of this malignancy; however only a few studies have investigated the microenvironment of the HCC background liver. The present review discusses prior molecular studies of hepatocarcinogenesis that focus on HCC and background liver tissues.

Entities:  

Keywords:  background liver factors; hepatocellular carcinoma; intrahepatic metastases; molecular alterations; multicentric occurrence

Year:  2016        PMID: 27900050      PMCID: PMC5104146          DOI: 10.3892/ol.2016.5141

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  125 in total

Review 1.  p53 gene in treatment of hepatic carcinoma: status quo.

Authors:  Yong-Song Guan; Zi La; Lin Yang; Qing He; Ping Li
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

2.  Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.

Authors:  Masahiro Okamoto; Tohru Utsunomiya; Shigeki Wakiyama; Masaji Hashimoto; Kengo Fukuzawa; Takahiro Ezaki; Taizo Hanai; Hiroshi Inoue; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

Review 3.  Recent advances in the surgical treatment of hepatocellular carcinoma.

Authors:  Zenichi Morise; Norihiko Kawabe; Hirokazu Tomishige; Hidetoshi Nagata; Jin Kawase; Satoshi Arakawa; Rie Yoshida; Masashi Isetani
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  Protein tyrosine kinase 7: a hepatocellular carcinoma-related gene detected by triple-combination array.

Authors:  Mitsuhiro Hishida; Yoshikuni Inokawa; Nao Takano; Yoko Nishikawa; Naoki Iwata; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Suguru Yamada; Goro Nakayama; Tsutomu Fujii; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera; Shuji Nomoto
Journal:  J Surg Res       Date:  2014-12-31       Impact factor: 2.192

Review 5.  TP53 and liver carcinogenesis.

Authors:  Frank Staib; S Perwez Hussain; Lorne J Hofseth; Xin W Wang; Curtis C Harris
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

Review 7.  Molecular profiling of hepatocellular carcinomas by cDNA microarray.

Authors:  Lian-Hai Zhang; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.

Authors:  Yizhou Zhang; Shoichi Takahashi; Akiko Tasaka; Tadahiko Yoshima; Hidenori Ochi; Kazuaki Chayama
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

View more
  7 in total

1.  miRNA-346 promotes proliferation, migration and invasion in liver cancer.

Authors:  Qiang Yu; Xia Yang; Weidong Duan; Chonghui Li; Ying Luo; Shichun Lu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

2.  Tumor-treating fields in combination with sorafenib restrain the proliferation of liver cancer in vitro.

Authors:  Yoonjung Jang; Won Seok Lee; Sei Sai; Jeong Yub Kim; Jong-Ki Kim; Eun Ho Kim
Journal:  Oncol Lett       Date:  2022-08-11       Impact factor: 3.111

3.  GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma.

Authors:  Kung-Hao Liang; Ta-Sen Yeh; Ren-Chin Wu; Chun-Nan Yeh; Chau-Ting Yeh
Journal:  Oncol Lett       Date:  2017-04-05       Impact factor: 2.967

4.  miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis.

Authors:  Chunhui Sun; Xun Yao; Qingyu Jiang; Xiuyong Sun
Journal:  Oncol Lett       Date:  2018-06-15       Impact factor: 2.967

5.  Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis.

Authors:  Carolin Czauderna; Alicia Poplawski; Colm J O'Rourke; Darko Castven; Benjamín Pérez-Aguilar; Diana Becker; Stephanie Heilmann-Heimbach; Margarete Odenthal; Wafa Amer; Marcel Schmiel; Uta Drebber; Harald Binder; Dirk A Ridder; Mario Schindeldecker; Beate K Straub; Peter R Galle; Jesper B Andersen; Snorri S Thorgeirsson; Young Nyun Park; Jens U Marquardt
Journal:  JCI Insight       Date:  2021-09-08

6.  Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.

Authors:  Davide Gentilini; Stefania Scala; Germano Gaudenzi; Paolo Garagnani; Miriam Capri; Matteo Cescon; Gian Luca Grazi; Maria Giulia Bacalini; Serena Pisoni; Alessandra Dicitore; Luisa Circelli; Sara Santagata; Francesco Izzo; Anna Maria Di Blasio; Luca Persani; Claudio Franceschi; Giovanni Vitale
Journal:  Oncotarget       Date:  2017-06-27

7.  Differentially expressed genes of HepG2 cells treated with gecko polypeptide mixture.

Authors:  Yi-Meng Duan; Ying Jin; Meng-Li Guo; Leng-Xin Duan; Jian-Gang Wang
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.